Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Current Treatment Options in Gastroenterology|September 28, 2007
Childhood and adolescent constipation: review and advances in managementNader N YoussefSeminars in Pediatric Surgery|February 4, 2010
Diagnosis and management of intestinal motility disordersCarlo Di Lorenzo, Nader N YoussefCurrent Gastroenterology Reports|April 2, 2008
Dyspepsia in childhood and adolescence: insights and treatment considerationsMaria E Perez, Nader N YoussefCurrent Treatment Options in Gastroenterology|September 5, 2002
Treatment Options for Refractory Childhood ConstipationNader N. Youssef, Carlo Di LorenzoDigestive Diseases (Basel, Switzerland)|July 20, 2006
Pediatric gastrointestinal motility--future directions and challengesNader N Youssef, Carlo Di LorenzoJournal of Clinical Pharmacology|March 11, 2024
Pharmacokinetics and Tolerability of a Single Dose of Apraglutide, a Novel, Long-Acting, Synthetic glucagon-like peptide-2 Analog With a Unique Pharmacologic Profile, in Individuals With Impaired Renal FunctionGérard Greig, Nader N Youssef, Federico BolognaniClinical and Translational Gastroenterology|June 26, 2015
Effect of Teduglutide, a Glucagon-like Peptide 2 Analog, on Citrulline Levels in Patients With Short Bowel Syndrome in Two Phase III Randomized TrialsDouglas L Seidner, Francisca Joly, Nader N YoussefAdolescent Medicine Clinics|July 24, 2004
Adolescent constipation: evaluation and managementNader N Youssef, Leslie Sanders, Carlo Di LorenzoJournal of Pediatric Surgery|December 25, 2003
Is there a role for surgery beyond colonic aganglionosis and anorectal malformations in children with intractable constipation?Nader N Youssef, Licia Pensabene, Edward Barksdale, et al.British Journal of Haematology|March 25, 2023
Pathophysiology of gastrointestinal acute graft-versus-host disease and the potential role of glucagon-like peptide 2Robert Zeiser, Yi-Bin Chen, Nader N Youssef, et al.Pageof 5